The later onset and lower NAFLD activity scores in L-CKO mice, compared to A-CKO mice, are likely due to the presence of LULL1 in the ER, which can partially activate torsinA. Here, TOR1A is linked to metabolic dysfunction-associated steatotic liver disease.